AdvanSource Biomaterials Corp
ASB
ASB was delisted on the 23rd of November, 2010.
1 hedge funds and large institutions have $12 invested in AdvanSource Biomaterials Corp in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$12 |
Top Sellers
ASB Hedge Fund Activity: Q4 2014 in Review
1 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in AdvanSource Biomaterials Corp (ASB) for Q4 2014, worth a combined $12.
Buyers outnumbered sellers: 1 fund opened new ASB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was B. Riley Wealth Advisors, opening a new position worth an estimated $12.
- 1 institutional investor held AdvanSource Biomaterials Corp (ASB) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $12 of AdvanSource Biomaterials Corp stock for Q4 2014.
- 1 fund opened new AdvanSource Biomaterials Corp positions in Q4 2014 and 0 closed out, a net change of +1 holder.
- The largest AdvanSource Biomaterials Corp buyer in Q4 2014 was B. Riley Wealth Advisors, an estimated $12 added.
Based on aggregated 13F filings for Q4 2014.